Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations


Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Monday, as follows:

Albemarle Corp. (NYSE:ALB) analysts reiterated it as a Buy with a 148 price target at Argus, with the independent research firm noting a strong outlook for the major lithium producer. The 52-wk trading range is 91.02 – 144.99, and the consensus analyst target price is at 144.11.

Allergan PLC (NYSE:AGN) was started as Buy and assigned a $200 price target at SunTrust Robinson Humphrey. The firm sees an attractive valuation in Allergan with manageable competition for its Botox. The 52-wk trading range is 156.00 – 256.80, and the consensus target price was 217.95.

Boston Scientific Corp. (NYSE:BSX) was started as Overweight and assigned a 31 price target at Piper Jaffray. The 52-week range is $24.02 to $29.93. The consensus target price is $31.60.

CTI BioPharma Corp. (NASDAQ:CTIC) was started with an Outperform rating and assigned a 5 price target at Oppenheimer. The firm believes that the primary driver of value is compound pacritinib for treatment of patients with myelofibrosis.

eBay Inc. (NASDAQ:EBAY) analysts reiterated EBAY as a Buy and the price target was raised to 50 at Argus, with the independent research firm noting that it has raised earnings expectations and that eBay deserves a higher multiple.

Have a terrific week.

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :